Effectiveness of evidence-based nursing care on the quality of life, cognitive performance, and psychological well-being of middle-aged individuals with mild cognitive impairment

Assessing the effect of evidence-based nursing care on the quality of life, cognitive performance, and psychological well-being of middle-aged individuals with mild cognitive impairment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151003024312N8

Enrollment

Registered

2025-09-14

Start date

2025-10-23

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment. A condition characterized by cognitive decline that is greater than expected for a person's age and education level, but not severe enough to interfere significantly with daily life.

Interventions

Intervention 1: Intervention group: In the present study, evidence-based nursing care refers to a Nurse-led Cognitive Support Toolkit, which will first be designed using the Iowa Model for evidence tr

Eligibility

Sex/Gender

All

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Individuals with mild cognitive impairment aged 40 to 65 years Meeting the Peterson criteria for diagnosing mild cognitive impairment of the amnestic type, either single-domain or multi-domain, as determined by the psychiatric nurse (researcher) Exclusion of dementia diagnosis based on self-reporting

Exclusion criteria

Exclusion criteria: Inability to participate in digital platforms and social media Existing known psychiatric disorders in the history and currently based on self-reporting Existing substance abuse based on self-reporting Having severe debilitating physical disorders or diseases currently (such as severe heart diseases, cancer, stroke, etc.) based on self-reporting Having severe sleep disorders based on self-reporting

Design outcomes

Primary

Measure	Time frame
Cognitive performance. Timepoint: During intervention and immediately after intervention. Method of measurement: Questionnaires, brief cognitive examination, and Montreal cognitive assessment.;Psychological performance. Timepoint: During intervention and immediately after intervention. Method of measurement: The 9-item Patient Health Questionnaire (PHQ-9) and the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7).;Quality of life. Timepoint: During intervention and immediately after intervention. Method of measurement: World Health Organization Quality of Life Questionnaire.	—

Measure

Time frame

Cognitive performance. Timepoint: During intervention and immediately after intervention. Method of measurement: Questionnaires, brief cognitive examination, and Montreal cognitive assessment.;Psychological performance. Timepoint: During intervention and immediately after intervention. Method of measurement: The 9-item Patient Health Questionnaire (PHQ-9) and the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7).;Quality of life. Timepoint: During intervention and immediately after intervention. Method of measurement: World Health Organization Quality of Life Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYalda Malek

Shahid Beheshti University of Medical Sciences

yalda.malek1380@gmail.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026